Background

Non-​​melanoma skin cancers such as squamous cell carcinomas and basal cell carcinomas can be treated using a variety of methods, but surgery remains the principal form of treatment used. As incomplete tumour excision portends a potentially increased risk of tumour recurrence, one of the primary goals of our dermatologic surgeons is to ensure that they are adequately excised. ​

Clinical Indicator

Rate of Incomplete Tumor Excision

Our rates of incomplete tumour excision for both Basal Cell Carcinomas and Squamous Cell Carcinomas show that we are consistently below the target of  4%. The experience of our surgeons, along with adherence to recommended excision margins, allows us to achieve favorable outcomes in our patients.​

Results: